Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

credit_-_daniel_leal-olivas-afp

CHMP rejects AB Science’s ALS therapy in Europe

April 23, 2018 Sales and Marketing AB Sciences, EMA, European Medicines Agency, ab science, als, masitinib, pharma

AB Science has revealed that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
News
frs-logo_0

Fresenius attempts to back out of $4.75bn deal for Akorn

April 23, 2018 Sales and Marketing

Fresenius has announced its intention to terminate the merger agreement with Akorn, over the $4.75 billion deal that the two …
News
houses-of-parliament-1055056_960_720

UK Ministers call on Vertex to speed up price negotiations

April 23, 2018 Sales and Marketing NHS, NICE, Orkambi, UK government, Vertex, biotech, drugs, pharma, pharmaceutical

After a parliamentary debate in the House of Commons regarding making Orkambi available to patients with cystic fibrosis (CF), MPs …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …
News

Lilly and Incyte’s resubmission of arthritis drug data fails to assuage FDA concerns

April 20, 2018 Medical Communications, Sales and Marketing Eli Lilly, FDA, Incyte, baricitinib, pharma, rheumatoid arthritis

Eli Lilly and Incyte are facing more complications in the US approval of their experimental rheumatoid arthritis (RA) drug baricitinib …
News
gw_pharma

FDA advisory committee sets GW Pharma up for approval

April 20, 2018 Medical Communications, Sales and Marketing Epidiolex, GW Pharma, biotech, drugs, pharma, pharmaceutical

After the FDA advisory committee unanimously recommended GW Pharma’s Epidiolex for approval, the chances of it not receiving the nod …
News

Allergan out but Takeda sticks to guns on Shire

April 20, 2018 Medical Communications, Sales and Marketing Allergan, Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …
News
shutterstock_244903099

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

April 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …
Feature
astrazeneca_building_white

AZ’s Tagrisso gets FDA nod in first-line EGFR-mutated lung cancer

April 19, 2018 Sales and Marketing AstraZeneca, Cancer, EGFR-TKIs, NSCLC, Tagrisso, lung cancer, pharma

AstraZeneca has announced that its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib) has received approval from …
News
merck_kgaa_pyramid_use_with_credit

Merck KGaA finds consumer health buyer in P&G for €3.4bn

April 19, 2018 Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …
News
iannone

Immunomedics’ whirlwind in the C-suite continues

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Appointment
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Appointment

BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer

April 18, 2018 Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma

The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …
News
epi-pen_1_3

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018 Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
News
gw_pharma

All indications point to approval for cannabis-based therapy

April 17, 2018 Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025